We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE
851
DELISTED
Noble Corporation
NE
$338K ﹤0.01%
48,138
+716
+2% +$4.34K
FLIR
852
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$337K ﹤0.01%
5,498
+2,390
+77% +$141K
TEVA icon
853
Teva Pharmaceuticals
TEVA
$36.2B
$334K ﹤0.01%
15,548
-38
-0.2% -$882
VRTX icon
854
Vertex Pharmaceuticals
VRTX
$122B
$334K ﹤0.01%
1,740
+46
+3% +$8.19K
TAL icon
855
TAL Education Group
TAL
$5.86B
$332K ﹤0.01%
12,931
-505
-4% -$16.3K
GAP
856
The Gap Inc
GAP
$7.07B
$332K ﹤0.01%
11,537
-12,618
-52% -$378K
LHCG
857
DELISTED
LHC Group LLC
LHCG
$329K ﹤0.01%
3,206
+2,950
+1,152% +$276K
BOX icon
858
Box
BOX
$4.18B
$328K ﹤0.01%
13,750
+5,145
+60% +$130K
JPM.PRB.CL
859
DELISTED
JPMorgan Chase & Co.
JPM.PRB.CL
$326K ﹤0.01%
12,745
SRPT icon
860
Sarepta Therapeutics
SRPT
$1.68B
$323K ﹤0.01%
2,000
HEDJ icon
861
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
$321K ﹤0.01%
10,206
-1,790
-15% -$57.4K
SNP
862
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$321K ﹤0.01%
3,200
-2,506
-44% -$237K
BF.A icon
863
Brown-Forman Class A
BF.A
$12.8B
$319K ﹤0.01%
6,298
WP
864
DELISTED
Worldpay, Inc.
WP
$319K ﹤0.01%
3,157
-941
-23% -$85.9K
COLB icon
865
Columbia Banking Systems
COLB
$8.74B
$318K ﹤0.01%
8,233
+2,873
+54% +$119K
PRAA icon
866
PRA Group
PRAA
$683M
$315K ﹤0.01%
8,758
ITT icon
867
ITT
ITT
$17.7B
$309K ﹤0.01%
5,058
-1,497
-23% -$86.4K
WABC icon
868
Westamerica Bancorp
WABC
$1.38B
$308K ﹤0.01%
5,125
+78
+2% +$4.79K
CHX
869
DELISTED
ChampionX
CHX
$307K ﹤0.01%
7,069
+35
+0.5% +$1.47K
KWR icon
870
Quaker Houghton
KWR
$2.63B
$306K ﹤0.01%
1,518
-18
-1% -$3.15K
MOG.A icon
871
Moog Inc Class A
MOG.A
$13.2B
$305K ﹤0.01%
3,555
+732
+26% +$57.7K
NEM icon
872
Newmont
NEM
$98.5B
$305K ﹤0.01%
10,153
-89,058
-90% -$3.01M
ALL.PRC.CL
873
DELISTED
The Allstate Corporation
ALL.PRC.CL
$303K ﹤0.01%
12,137
LSXMA
874
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$302K ﹤0.01%
9,654
-19,776
-67% -$664K
IQV icon
875
IQVIA
IQV
$35.6B
$301K ﹤0.01%
2,324
-97
-4% -$11.6K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.